Concepedia

Nadiia Lypova

NL

Statistics

Publications

8

Citations

197

H-Index

8

Active since

2014

Affiliations

University of Louisville(Current)

Palladin Institute of Biochemistry

National Academy of Sciences of Ukraine

Bogomolets National Medical University

James Graham Brown Foundation

Nadiia Lypova is an author at University of Louisville specializing in oncology, molecular oncology, and cancer cell signaling.

ORCID

Publications per year

2014–2021

8

Publications

8

Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non–small cell lung cancer cell survival

Nadiia Lypova, Sucheta Telang, Jason Chesney et al. · Journal of Biological Chemistry · 2019 · 37 citations · Full text

, , +17

Inhibition of kinase and endoribonuclease activity of ERN1/IRE1α affects expression of proliferationrelated genes in U87 glioma cells

Dariia O. Tsymbal, Dmytro O. Minchenko, Michel Moenner et al. · Endoplasmic Reticulum Stress in Diseases · 2015 · 33 citations · Full text

, , +15

Inhibition of ERN1 modifies the hypoxic regulation of the expression of TP53-related genes in U87 glioma cells

Dmytro O. Minchenko, Serhii V. Danilovskyi, Iryna V. Kryvdiuk et al. · Endoplasmic Reticulum Stress in Diseases · 2014 · 31 citations · Full text

, , +17

Transcriptomic Profiling Identifies Differentially Expressed Genes in Palbociclib-Resistant ER+ MCF7 Breast Cancer Cells

Lilibeth Lanceta, Conor O’Neill, Nadiia Lypova et al. · Genes · 2020 · 24 citations · Full text

, , +17

Targeting Palbociclib-Resistant Estrogen Receptor-Positive Breast Cancer Cells via Oncolytic Virotherapy

Nadiia Lypova, Lilibeth Lanceta, Stephanie P. Vega et al. · Cancers · 2019 · 23 citations · Full text

, , +16

1–5 of 8